Zydus Lifesciences announced that the USFDA conducted a surveillance inspection at the group's API Manufacturing site situated at Ambernath in Maharashtra. The inspection was conducted from February 10th to 14th, 2025.
The inspection concluded with NIL observations.
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
Unlimited Trading starting at ₹249
Open Trading Account
